Chairman & CEO of Edwards Lifesciences Corp (30-Year Financial, Insider Trades) Michael A Mussallem (insider trades) sold 22,850 shares of EW on 08/22/2019 at an average price of $216.7 a share. The total sale was $5 million.
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $45.06 billion; its shares were traded at around $216.67 with a P/E ratio of 63.55 and P/S ratio of 11.60. Edwards Lifesciences Corp had annual average EBITDA growth of 17.70% over the past ten years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 4-star. GuruFocus has detected 1 severe warning sign with Edwards Lifesciences Corp. .
CEO Recent Trades:
- Chairman & CEO Michael A Mussallem sold 22,850 shares of EW stock on 08/22/2019 at the average price of $216.7. The price of the stock has decreased by 0.01% since.
Directors and Officers Recent Trades:
- Director William J Phd Link sold 10,214 shares of EW stock on 08/21/2019 at the average price of $221.86. The price of the stock has decreased by 2.34% since.
- CVP, Critical Care Catherine M. Szyman sold 700 shares of EW stock on 08/15/2019 at the average price of $214.53. The price of the stock has increased by 1% since.
- CVP,Strategy/Corp Development Donald E Jr Bobo sold 5,369 shares of EW stock on 08/09/2019 at the average price of $216.26. The price of the stock has increased by 0.19% since.
- CVP, Japan & Intercontinental Huimin Wang sold 4,650 shares of EW stock on 08/05/2019 at the average price of $211.54. The price of the stock has increased by 2.43% since.
- CVP, TAVR Larry L Wood sold 6,716 shares of EW stock on 08/01/2019 at the average price of $213.31. The price of the stock has increased by 1.58% since.
For the complete insider trading history of EW, click here
.
